期刊列表 » 期刊详情

1、投稿方式：在线投稿。

2、刊内网址（202506期）：

http://www.zhhlzzs.com

https://www.journals.elsevier.com/international-journal-of-nursing-sciences

自动跳转至：

https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences

3、投稿系统：https://submit.elsevier.com/IJNSS

4、刊内邮箱：cnaijns@163.com

5、刊内电话：010-53779541

6、出刊日期：双月刊，一年出版六期。

7、刊内微信公众号：中华护理杂志社（zhhlzzs）

2026年1月16日星期五

Guide for authors

【官网信息】

Introduction

Journal Announcements

Effective

8 December 2025, the journal has transitioned to a new submission

platform: https://submit.elsevier.com/IJNSS. New submissions should be

made via this platform. Manuscripts submitted before this date will

continue to be managed in Editorial Manager (EM); please also submit any

revisions through EM at

https://www.editorialmanager.com/ijnss/default.aspx

International

Journal of Nursing Sciences (IJNSS, Print ISSN 2096-6296, and Online

ISSN 2352-0132, CN:10-1444/R) is the official peer-reviewed research

journal of Chinese Nursing Association. This journal aims to promote

excellence in nursing and health care through the dissemination of the

latest, evidence-based, peer-reviewed clinical information and original

research, providing an international platform for exchanging knowledge,

research findings and nursing practice experience. IJNSS publishes four

issues per year in Jan/Apr/Jul/Oct. IJNSS intended readership includes

practicing nurses in all spheres and at all levels who are committed to

advancing practice and professional development on the basis of new

knowledge and evidence; managers and senior members of the nursing;

nurse educators and nursing students etc. IJNSS seeks to enrich insight

into clinical need and the implications for nursing intervention and

models of service delivery. Contributions are welcomed from other health

professions on issues that have a direct impact on nursing practice.

Types of article

The IJNSS publishes original research papers, reviews, discussion papers, editorial and letters to the editor.

Before you begin

Reporting Guidelines

The

guidelines listed below should be followed where appropriate. Please

use these guidelines to structure your article. Structured abstracts and

flow diagrams should be uploaded with your submission; these will be

published alongside the final version of your paper.

CONSORT

(for reporting of randomized controlled trials: please use the

appropriate extension to the CONSORT statement, including TIDieR

checklist to better reporting of interventions)

STROBE (for reporting of observational cohort, case control and cross sectional studies)

PRISMA (for reporting of systematic reviews)

SRQR (for reporting of qualitative studies)

SQUIRE (for reporting of quality improvement studies, including SQUIRE-EDU for educational improvement)

CARE (for case report, including extensions for specific case report)

CHEERS (for reporting of health economic evaluations)

STARD

(for reporting of diagnostic accuracy studies, including the TRIPOD

statement for reporting of a multivariable prediction model for

individual prognosis or diagnosis)

AGREE (for reporting of clinical practice guidelines)

The Equator Network

(http://www.equator-network.org/resource-centre/library-of-health-research-reporting/library/

) provides a comprehensive list of reporting guidelines.

Ethical Approval

All

studies must be conducted to a high ethical standard and must adhere to

local regulations and standards for gaining scrutiny and approval.

The

work described in your article must have been carried out in accordance

with The Code of Ethics of the World Medical Association (Declaration

of Helsinki) for experiments involving humans

http://www.wma.net/en/30publications/10policies/b3/; EC Directive

86/609/EEC for animal experiments

http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm.

This must be stated at an appropriate point in the article.

For

information on Ethics in Publishing and Ethical guidelines for journal

publication see https://www.elsevier.com/authorethics.

Informed consent and patient details

Studies

on patients or volunteers require ethics committee approval and

informed consent, which should be documented in the paper. Appropriate

consents, permissions and releases must be obtained where an author

wishes to include case details or other personal information or images

of patients and any other individuals in an Elsevier publication.

Written consents must be retained by the author but copies should not be

provided to the journal. Only if specifically requested by the journal

in exceptional circumstances (for example if a legal issue arises) the

author must provide copies of the consents or evidence that such

consents have been obtained. For more information, please review the

Elsevier Policy on the Use of Images or Personal Information of Patients

or other Individuals. Unless you have written permission from the

patient (or, where applicable, the next of kin), the personal details of

any patient included in any part of the article and in any

supplementary materials (including all illustrations and videos) must be

removed before submission.

https://www.elsevier.com/authors/journal-authors/policies-and-ethics

Conflict of Interest

All

authors are requested to disclose any actual or potential conflict of

interest including any financial, personal or other relationships with

other people or organizations within three years of beginning the

submitted work that could inappropriately influence, or be perceived to

influence, their work. See

alsohttps://www.elsevier.com/conflictsofinterest. Further information

and an example of a Conflict of Interest form can be found

at:https://service.elsevier.com/app/answers/detail/a_id/286/supporthub/publishing.

The

IJNSS use the ICMJE Form for Disclosure of Potential Conflicts of

Interest to generate a disclosure statement for your manuscript. See

also https://www.icmje.org/conflicts-of-interest/

Trial or other study registration

We

encourage the prospective registration of studies. Where a study has

been registered please give the number in the registration number within

the title, abstract or body of the paper as appropriate.

Submission declaration and verification

Submission

of an article implies that the work described has not been published

previously (except in the form of an abstract or as part of a published

lecture or academic thesis or as an electronic preprint, see 'Multiple,

redundant or concurrent publication' section of our ethics policy for

more information), that it is not under consideration for publication

elsewhere, that its publication is approved by all authors and tacitly

or explicitly by the responsible authorities where the work was carried

out, and that, if accepted, it will not be published elsewhere in the

same form, in English or in any other language, including electronically

without the written consent of the copyright-holder. To verify

originality, your article may be checked by the originality detection

service CrossCheck.

Contributors and Acknowledgements

All

authors should have made substantial contributions to all of the

following: (1) the conception and design of the study, or acquisition of

data, or analysis and interpretation of data, (2) drafting the article

or revising it critically for important intellectual content, (3) final

approval of the version to be submitted.

In

the covering letter to the editorial office, we ask that roles for each

and every author be individually described, with reference to the

criteria for authorship. You must make a true statement that all authors

have approved the final article and acknowledge that all those entitled

to authorship are listed as authors.

Those

who meet some but not all of the criteria for authors can be identified

as 'contributors' at the end of the manuscript with their contribution

specified. All those individuals who provided help during the research

(e.g., collecting data, providing language help, writing assistance or

proofreading the article, etc.) that do not meet criteria for authorship

should be acknowledged in the paper.

Changes to authorship

Authors

are expected to consider carefully the list and order of authors before

submitting their manuscript and provide the definitive list of authors

at the time of the original submission. Any addition, deletion or

rearrangement of author names in the authorship list should be made only

before the manuscript has been accepted and only if approved by the

journal Editor. To request such a change, the Editor must receive the

following from the corresponding author: (a) the reason for the change

in author list and (b) written confirmation (e-mail, letter) from all

authors that they agree with the addition, removal or rearrangement. In

the case of addition or removal of authors, this includes confirmation

from the author being added or removed. Only in exceptional

circumstances will the Editor consider the addition, deletion or

rearrangement of authors after the manuscript has been accepted. While

the Editor considers the request, publication of the manuscript will be

suspended. If the manuscript has already been published in an online

issue, any requests approved by the Editor will result in a corrigendum.

Copyright

Upon

acceptance of an article, authors will be asked to complete a 'Journal

Publishing Agreement' (for more information on this and copyright, see

https://www.elsevier.com/about/company-information/policies/copyright).

An e-mail will be sent to the corresponding author confirming receipt of

the manuscript together with a 'Journal Publishing Agreement' form or a

link to the online version of this agreement.

If

excerpts from other copyrighted works are included, the author(s) must

obtain written permission from the copyright owners and credit the

source(s) in the article.

For

open access articles: Upon acceptance of an article, authors will be

asked to complete an 'Exclusive License Agreement' (for more information

see https://www.elsevier.com/OAauthoragreement). Permitted third party

reuse of open access articles is determined by the author's choice of

user license (seehttps://www.elsevier.com/openaccesslicenses).

Author rights

As

an author you (or your employer or institution) have certain rights to

reuse your work. For more information see

https://www.elsevier.com/about/company-information/policies/copyright.

Elsevier supports responsible sharing

Find

out how you can share your research published in Elsevier journals on

https://www.elsevier.com/authors/journal-authors/submit-your-paper/sharing-and-promoting-your-article

Role of the funding source

You

are requested to identify who provided financial support for the

conduct of the research and/or preparation of the article and to briefly

describe the role of the sponsor(s), if any, in study design; in the

collection, analysis and interpretation of data; in the writing of the

report; and in the decision to submit the article for publication. If

the funding source(s) had no such involvement then this should be

stated.

If you received no external funding (i.e. other than your main employer) please state 'no external funding'.

Funding body agreements and policies

Elsevier

has established a number of agreements with funding bodies which allow

authors to comply with their funder's open access policies. Some funding

bodies will reimburse the author for the Open Access Publication Fee.

Details of existing agreements are available online.

After

acceptance, open access papers will be published under a noncommercial

license. For authors requiring a commercial CC BY license, you can apply

after your manuscript is accepted for publication.

Open access

Every

peer-reviewed research article appearing in this journal will be

published open access. This means that the article is universally and

freely accessible via the internet in perpetuity, in an easily readable

format immediately after publication. To provide open access, the

authors (or funders and institutes) will be charged an article

processing charge (APC) of 150 USD per page (excluding taxes).

A

CC user license manages the reuse of the article (see

https://www.elsevier.com/openaccesslicenses). All articles will be

published under the following license:

Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

For

non-commercial purposes, lets others distribute and copy the article,

and to include in a collective work (such as an anthology), as long as

they credit the author(s) and provided they do not alter or modify the

article.

Please visit our Open Access page for more information about open access publishing in this journal.

Elsevier’s Researcher Academy

If

you would like help to improve your submission or navigate the

publication process, support is available via “Researcher Academy.”

Researcher

Academy offers free e-learning modules, webinars, downloadable guides

and research writing and peer review process resources.

Language (usage and editing services)

Please

write your text in good English (American or British usage is accepted,

but not a mixture of these). Authors who feel their English language

manuscript may require editing to eliminate possible grammatical or

spelling errors and to conform to correct scientific English may wish to

use the English Language Editing service available from Elsevier's

WebShop.

Submission

Submit online

Our

online submission system guides you through the process steps of

entering your manuscript details and uploading your files. The system

converts your article files to a single PDF file used in the peer-review

process.

Editable

files (e.g., Word, LaTeX) are required to typeset your article for

final publication. All correspondence, including notification of the

editor's decision and requests for revision, is sent by email.

Please submit via https://submit.elsevier.com/IJNSS

Peer review

This

journal operates a double blind review process. All contributions will

be initially assessed by the editor for suitability for the journal.

Papers deemed suitable are then sent to a minimum of two independent

expert reviewers to assess the scientific quality of the paper. The

Editor is responsible for the final decision regarding acceptance or

rejection of articles. The Editor's decision is final. More information

on types of peer review.

Authors

may choose to submit the names and institutional e-mail addresses of

three potential referees. Note that the editor retains the sole right to

decide whether or not the suggested reviewers are used.

Declaration of generative AI in scientific writing

Authors must declare the use of generative AI in the manuscript preparation process upon submission of the paper.

Elsevier

recognizes the potential of generative AI and AI-assisted technologies

(“AI Tools”), when used responsibly, to help researchers work

efficiently, gain critical insights fast and achieve better outcomes.

Increasingly, these tools, including AI agents and deep research tools,

are helping researchers to synthesize complex literature, provide an

overview of a field or research question, identify research gaps,

generate ideas, and provide tailored support for tasks such as content

organization and improving language and readability.

Authors

preparing a manuscript for an Elsevier journal can use AI Tools to

support them. However, these tools must never be used as a substitute

for human critical thinking, expertise and evaluation. AI technology

should always be applied with human oversight and control.

Ultimately, authors are responsible and accountable for the contents of their work. This includes accountability for:

Carefully

reviewing and verifying the accuracy, comprehensiveness, and

impartiality of all AI-generated output (including checking the sources,

as AI-generated references can be incorrect or fabricated).

Editing

and adapting all material thoroughly to ensure the manuscript

represents the author’s authentic and original contribution and reflects

their own analysis, interpretation, insights and ideas.

Ensuring

the use of any tools or sources, AI-based or otherwise, is made clear

and transparent to readers. If AI Tools have been used, we require a

disclosure statement upon submission; please see example below.

Ensuring

the manuscript is developed in a way that safeguards data privacy,

intellectual property and other rights, by checking the terms and

conditions of any AI tool that is used.

Finally,

authors must not list or cite AI Tools as an author or co-author on the

manuscript since authorship implies responsibilities and tasks that can

only be attributed to, and performed by, humans.

The

use of AI Tools in the manuscript preparation process must be declared

by adding a statement at the end of the manuscript when the paper is

first submitted. The statement will appear in the published work and

should be placed in a new section before the references list.

......

更多详见：

https://www.sciencedirect.com/journal/international-journal-of-nursing-sciences/publish/guide-for-authors